Mark A Boyd Selected Research

Cytochrome P-450 CYP2B6 (CYP2B6)

7/2015

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark A Boyd Research Topics

Disease

6	Infections 09/2023 - 01/2014
3	Coinfection 01/2014 - 10/2003
2	Necrosis 11/2021 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2017 - 01/2013
2	Tuberculosis (Tuberculoses) 01/2017 - 04/2006
2	Disease Progression 01/2017 - 05/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2014 - 01/2010
2	Injection Site Reaction 01/2010 - 01/2008
1	Atrial Fibrillation 09/2021
1	Vomiting 01/2021
1	Chlamydia Infections 01/2021
1	Sepsis (Septicemia) 01/2021
1	Nausea 01/2021
1	Diarrhea 01/2021
1	Inflammation (Inflammations) 01/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2020
1	Tobacco Use Disorder (Nicotine Dependence) 12/2018
1	Chronic Renal Insufficiency 11/2017
1	Cryptococcal Meningitis 01/2017
1	Malnutrition (Nutritional Deficiencies) 05/2016
1	Substance-Related Disorders (Drug Abuse) 05/2016
1	Genetic Risk Score 07/2015
1	Viremia 05/2014
1	HIV Infections (HIV Infection) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013
1	Lipodystrophy 01/2013
1	Pyuria 06/2006
1	Nephrolithiasis 06/2006
1	Hepatitis 05/2004

Drug/Important Bio-Agent (IBA)

4	Ritonavir (Norvir)FDA Link 01/2015 - 04/2006
4	Lopinavir FDA Link 01/2015 - 01/2013
3	NucleosidesIBA 01/2015 - 01/2013
3	Raltegravir Potassium FDA Link 01/2015 - 01/2013
3	Indinavir (Crixivan)FDA Link 01/2014 - 04/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2023 - 01/2021
2	Lipopolysaccharide ReceptorsIBA 11/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2021
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2021 - 01/2020
2	Reverse Transcriptase InhibitorsIBA 01/2018 - 01/2013
2	Tenofovir (Viread)FDA Link 05/2016 - 01/2014
2	Atazanavir Sulfate (Reyataz)FDA Link 07/2015 - 01/2014
2	Enfuvirtide (Fuzeon)FDA Link 01/2010 - 01/2008
2	RNA (Ribonucleic Acid)IBA 06/2006 - 05/2004
1	C-Reactive ProteinIBA 11/2021
1	InterleukinsIBA 11/2021
1	fibrin fragment D (D-dimer)IBA 11/2021
1	NeopterinIBA 11/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	Anti-HIV Agents (AIDS Drugs)IBA 11/2017
1	lipoarabinomannan (LAM)IBA 01/2017
1	Nevirapine (Viramune)FDA Link 07/2015
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 07/2015
1	Cytochrome P-450 CYP3AIBA 07/2015
1	Antiviral Agents (Antivirals)IBA 01/2014
1	NucleotidesIBA 01/2013
1	LipidsIBA 01/2013
1	CreatinineIBA 06/2006
1	efavirenz (Sustiva)FDA Link 04/2006
1	N-acetyltalosaminuronic acid (NAT)IBA 05/2004

Therapy/Procedure

12	Therapeutics 01/2018 - 10/2003
2	Highly Active Antiretroviral Therapy (HAART) 01/2010 - 05/2004
1	Catheter Ablation 09/2021
1	Aftercare (After-Treatment) 01/2020
1	Drug Therapy (Chemotherapy) 12/2018